Anthem Biosciences (ANTHEM) Share Price Falls 2.72%: Stock News, Valuation and Sector Check
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price fell to Rs 893.40 on 22 September 2026, down 2.72% from the previous close of Rs 918.40. The company’s market capitalisation stood at Rs 52,619.43 crore, placing it in the Large Cap category. The decline came without a company-specific catalyst in the supplied data, so the move is best read as a verified same-day price event rather than a explained event. Anthem Biosciences Share Price Today therefore matters for investors looking at price action, valuation and sector context rather than a single news trigger. Univest is tracking the move with the same data lens used for broader Stock News and Share Price Update coverage.
The stock opened at Rs 918.40, matched its previous close at the open, touched an intraday high of Rs 918.75 and a low of Rs 892.25. Turnover stood at Rs 1.5 crore. That combination shows Anthem Biosciences Share Price Today moved lower after a flat start, with the day’s range remaining relatively contained. In Univest coverage terms, this is a price fall story supported by exact figures, not by a stated event driver. The next sections of this Anthem Biosciences Stock News note focus on what the numbers say about valuation, fundamentals, sector comparison and peers.
Anthem Biosciences (ANTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 893.4 |
| Previous Close | Rs 918.4 |
| Today's Move | -Rs 25.00 (-2.72%) |
| Open | Rs 918.4 |
| High | Rs 918.75 |
| Low | Rs 892.25 |
| Turnover | Rs 1.5 crore |
| Market Capitalisation | Rs 52,619.43 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Share Price Today ended at Rs 893.40 after a day change of Rs -25.00, or -2.72%, versus the previous close of Rs 918.40. The stock opened exactly at Rs 918.40, which means the day started unchanged before moving lower during the session. The intraday high was Rs 918.75 and the intraday low was Rs 892.25, so the gap between the day’s top and bottom was Rs 26.50. That range is useful context for today’s share price fall because it shows the move was concentrated within a narrow band. The market-cap category supplied for Anthem Biosciences is Large Cap, and its market capitalisation is Rs 52,619.43 crore. Turnover was Rs 1.5 crore. On the day’s evidence alone, Anthem Biosciences Share Price reflects a clear decline, but the data does not establish a company-specific catalyst. For readers tracking Anthem Biosciences Share Price on Univest, the key takeaway is the exact decline, the opening level, the close and the market value context.
Anthem Biosciences (ANTHEM) Fundamental Analysis
Use Anthem Biosciences (ANTHEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 52,619.43 crore |
| P/E Ratio | 89.86x |
| P/B Ratio | 16.54x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.22% |
Anthem Biosciences Share Price sits against a rich valuation backdrop. The stock’s market capitalisation is Rs 52,619.43 crore, which is far above the healthcare industry median in the supplied benchmark set. The P/E ratio is 89.86 and the P/B ratio is 16.54. In the same sector and industry benchmark scope, the company P/E is above the median P/E of 32.62 and above the average of 49.51, while the company P/B is also above the benchmark median of 3 and average of 4.35. ROE is 21.98% and ROCE is 29.62%, both above the benchmark medians of 11.74% and 13.63% respectively. EPS is Rs 10.22, book value is Rs 55.53 and dividend yield is 0.22%. These figures suggest the Anthem Biosciences Share Price conversation is not only about one day’s fall; it is also about how the stock is valued relative to earnings, accounting equity and return ratios. On the supplied numbers, Univest readers can see a company with strong return metrics, a premium valuation and a dividend yield that remains a small part of the profile. That is the relevant fundamental context behind today’s stock news.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 89.86x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 16.54x |
| Benchmark Median P/B | 3x |
| Benchmark Average P/B | 4.35x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.74% |
| Benchmark Average ROE | 10.79% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.63% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 52,619.43 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
| Benchmark Average Market Cap | Rs 14,202.67 crore |
Within Healthcare and the Pharmaceuticals & Drugs industry, Anthem Biosciences Share Price can be compared against a benchmark pool of 200 companies in the same industry. The company’s P/E of 89.86 is above the benchmark median of 32.62 and the benchmark average of 49.51. Its P/B of 16.54 is also above the benchmark median of 3 and the benchmark average of 4.35. ROE at 21.98% is above the industry median of 11.74% and average of 10.79%, while ROCE at 29.62% is above the median of 13.63% and average of 13.4%. The benchmark market cap median is Rs 746.45 crore, the average is Rs 14,202.67 crore, and Anthem Biosciences is well above both at Rs 52,619.43 crore. In this sector context, Anthem Biosciences Share Price is being viewed through the lens of premium valuation and strong return ratios rather than through a simple price-only move. The supplied data also places it alongside a wide industry sample, which is useful for Univest’s stock analysis approach.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Peer comparison shows where Anthem Biosciences Share Price stands inside the pharmaceuticals set. Against Sun Pharmaceutical Industries at P/E 37.05, P/B 5.18, ROE 14.85% and ROCE 19.11%, Anthem trades at a materially higher P/E and P/B with stronger return ratios. Against Divi’s Laboratories at P/E 85.6 and P/B 14.18, Anthem’s valuation is still higher on both multiples, while ROE and ROCE are stronger. Torrent Pharmaceuticals shows P/E 86.64, P/B 21.05, ROE 26.76% and ROCE 19.27%; Anthem’s P/E is a little higher, P/B is lower, ROE is lower and ROCE is higher. Zydus Lifesciences has a much lower P/E of 25.67 and P/B of 4.3, with ROE of 19.69% and ROCE of 21.39%, so Anthem is richer on valuation and better on ROCE. For Univest readers, this makes Anthem Biosciences Share Price a premium-valuation stock inside a varied peer set.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price fell 2.72% to Rs 893.40 from Rs 918.40.
- The day’s open was Rs 918.40, the high was Rs 918.75 and the low was Rs 892.25.
- Market capitalisation stood at Rs 52,619.43 crore, and the stock is classified as Large Cap.
- P/E is 89.86, P/B is 16.54, ROE is 21.98% and ROCE is 29.62%.
- Turnover was Rs 1.5 crore, which is part of the factual trade record for the session.
About Anthem Biosciences
Anthem Biosciences operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company classification places it within a large listed universe used by Univest for stock news, market cap context and relative valuation checks. The available data in this note focuses on market performance, returns, valuation and sector positioning rather than business-description detail. For readers following Anthem Biosciences Share Price, that means the most verifiable story today comes from the listed numbers: price, market value, earnings multiples, return ratios and peer comparison. Univest uses the same structure across its Stock News and Share Price Update coverage to keep the analysis factual and comparable.
Track Anthem Biosciences Share Price on Univest
Investors following Anthem Biosciences Share Price can track the live share price, share price news, financial ratios, shareholding pattern, 52-week levels and market insights on Univest. The platform brings together stock analysis, fundamental analysis and company news in one place, helping readers review today’s decline alongside the broader valuation picture.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Anthem Biosciences Share Price fall today?
Ans. The supplied data shows Anthem Biosciences Share Price fell 2.72% to Rs 893.40, but it does not establish a company-specific catalyst. The move is confirmed as a same-day price event with exact open, high, low and close levels.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price today is Rs 893.40. It declined from the previous close of Rs 918.40, which means the stock ended Rs 25.00 lower on the session and stayed within a range between Rs 892.25 and Rs 918.75.
How much did Anthem Biosciences Share Price decline?
Ans. Anthem Biosciences Share Price declined by Rs 25.00, or 2.72%, in today’s session. The open was Rs 918.40, the high was Rs 918.75 and the low was Rs 892.25, so the close settled near the day’s lower end.
What is Anthem Biosciences market capitalisation?
Ans. Anthem Biosciences has a market capitalisation of Rs 52,619.43 crore. That places it in the Large Cap category in the supplied data and far above the benchmark median market cap of Rs 746.45 crore for the same industry set.
How does Anthem Biosciences look on valuation and returns?
Ans. Anthem Biosciences has a P/E of 89.86, P/B of 16.54, ROE of 21.98% and ROCE of 29.62%. Compared with the industry benchmark, the return ratios are above the median, while valuation multiples remain above benchmark levels.
